GeneDx Holdings Corp. Securities Fraud Lawsuit Filed for Investors
A lawsuit alleges GeneDx Holdings Corp. violated securities laws. Investors have an opportunity to join the class action, initiated by The Schall Law Firm.
The Schall Law Firm has initiated a class action lawsuit against GeneDx Holdings Corp., traded on NASDAQ under the ticker WGS. The complaint alleges the company committed securities fraud by violating Sections 10(b) and 20(a) of the Securities Exchange Act.
The allegations center on GeneDx's purported false and misleading statements made to investors during a specific period. These statements allegedly concerned material aspects of the company's business and financial condition. Investors who incurred losses buying GeneDx stock within this timeframe may be eligible for compensation.
The lawsuit seeks to address alleged violations that impacted the company's stock price. The Schall Law Firm is now calling on investors who believe they have suffered losses and wish to participate in the litigation to register with the firm promptly.
With a deadline to join the action approaching, investors should contact The Schall Law Firm for more information regarding their potential participation and the protection of their rights.